These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027 [TBL] [Abstract][Full Text] [Related]
33. The impact of heparin coated circuits upon metabolism in vital organs: effect upon cerebral and renal function during and after cardiopulmonary bypass. de Vroege R; Stooker W; van Oeveren W; Bakker EW; Huybregts RA; van Klarenbosch J; van Kamp GJ; Hack CE; Eijsman L; Wildevuur CR ASAIO J; 2005; 51(1):103-9. PubMed ID: 15745143 [TBL] [Abstract][Full Text] [Related]
34. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. Moen O; Fosse E; Brockmeier V; Andersson C; Mollnes TE; Høgåsen K; Venge P Ann Thorac Surg; 1995 Nov; 60(5):1317-23. PubMed ID: 8526620 [TBL] [Abstract][Full Text] [Related]
35. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating. Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821 [TBL] [Abstract][Full Text] [Related]
36. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Nilsson L; Storm KE; Thelin S; Bagge L; Hultman J; Thorelius J; Nilsson U Artif Organs; 1990 Feb; 14(1):46-8. PubMed ID: 2302076 [TBL] [Abstract][Full Text] [Related]
37. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380 [TBL] [Abstract][Full Text] [Related]
38. Biocompatibility and pathways of initial complement pathway activation with Phisio- and PMEA-coated cardiopulmonary bypass circuits during open-heart surgery. Thiara AS; Mollnes TE; Videm V; Andersen VY; Svennevig K; Kolset SO; Fiane AE Perfusion; 2011 Mar; 26(2):107-14. PubMed ID: 21177724 [TBL] [Abstract][Full Text] [Related]
39. Superior biocompatibility of heparin-bonded circuits in pediatric cardiopulmonary bypass. Ozawa T; Yoshihara K; Koyama N; Yamazaki S; Takanashi Y Jpn J Thorac Cardiovasc Surg; 1999 Dec; 47(12):592-9. PubMed ID: 10658376 [TBL] [Abstract][Full Text] [Related]
40. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]